IN2014MN02116A - - Google Patents

Download PDF

Info

Publication number
IN2014MN02116A
IN2014MN02116A IN2116MUN2014A IN2014MN02116A IN 2014MN02116 A IN2014MN02116 A IN 2014MN02116A IN 2116MUN2014 A IN2116MUN2014 A IN 2116MUN2014A IN 2014MN02116 A IN2014MN02116 A IN 2014MN02116A
Authority
IN
India
Prior art keywords
solid composition
ethylbicyclo
hept
proving
aminomethyl
Prior art date
Application number
Other languages
English (en)
Inventor
TAJIRIShinichiro
Masami Takemura
YOSHINAGAShinji
Original Assignee
Daiichi Sankyo Companyltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51658423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014MN02116(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Companyltd filed Critical Daiichi Sankyo Companyltd
Publication of IN2014MN02116A publication Critical patent/IN2014MN02116A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2116MUN2014 2013-04-04 2014-04-03 IN2014MN02116A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013079006 2013-04-04
PCT/JP2014/059812 WO2014163132A1 (ja) 2013-04-04 2014-04-03 アミノカルボン酸の塩の固形組成物

Publications (1)

Publication Number Publication Date
IN2014MN02116A true IN2014MN02116A (de) 2015-09-04

Family

ID=51658423

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2116MUN2014 IN2014MN02116A (de) 2013-04-04 2014-04-03

Country Status (11)

Country Link
US (1) US9675570B2 (de)
EP (1) EP2826477B1 (de)
JP (1) JP5627062B1 (de)
KR (1) KR102142257B1 (de)
CN (1) CN104334169B (de)
BR (1) BR112014029538B1 (de)
CA (1) CA2870675C (de)
ES (1) ES2638420T3 (de)
IN (1) IN2014MN02116A (de)
TW (1) TWI645863B (de)
WO (1) WO2014163132A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017019918B1 (pt) * 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
CN107427483B (zh) * 2015-03-19 2021-06-29 第一三共株式会社 含有着色剂的固体制剂
FR3075662B1 (fr) * 2017-12-21 2022-06-24 Ifp Energies Now Procede de pretraitement pour ameliorer le remplissage d'une enceinte avec des particules solides
ES2943883T3 (es) 2018-07-30 2023-06-16 Daiichi Sankyo Co Ltd Formulación de fármaco sólido que contiene estabilizador
JP7145121B2 (ja) * 2019-05-31 2022-09-30 信越化学工業株式会社 錠剤の製造方法
CN114786653B (zh) 2019-12-23 2023-10-31 第一三共株式会社 具有光滑表面的薄膜包衣片剂
CN115803020A (zh) * 2020-07-27 2023-03-14 第一三共株式会社 含有苯磺酸米洛巴林的口腔崩解片剂
JPWO2024248079A1 (de) 2023-06-02 2024-12-05
CN119770439A (zh) * 2025-01-13 2025-04-08 成都药宜立康医药科技有限公司 一种苯磺酸美洛加巴林片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
JPH11189547A (ja) * 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
WO2006056874A1 (en) * 2004-11-25 2006-06-01 Pfizer Limited Salt form
GB0425955D0 (en) * 2004-11-25 2004-12-29 Pfizer Ltd Salt form
JP4691434B2 (ja) * 2005-11-08 2011-06-01 東和薬品株式会社 安定化されたカベルゴリン固形製剤
BRPI0818193B8 (pt) * 2007-09-28 2021-05-25 Daiichi Sankyo Co Ltd composto, composição farmacêutica, e, uso de um composto
WO2010021300A1 (ja) * 2008-08-18 2010-02-25 三菱商事フードテック株式会社 新規マンニトール打錠用賦形剤
JP2010241796A (ja) * 2009-03-17 2010-10-28 Daiichi Sankyo Co Ltd 二環性γ−アミノ酸誘導体含有医薬組成物
JP5557292B2 (ja) * 2009-03-26 2014-07-23 第一三共株式会社 二環性γ−アミノ酸誘導体の製造方法
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠

Also Published As

Publication number Publication date
EP2826477A1 (de) 2015-01-21
EP2826477A4 (de) 2015-09-09
WO2014163132A1 (ja) 2014-10-09
US9675570B2 (en) 2017-06-13
KR102142257B1 (ko) 2020-08-07
HK1204559A1 (en) 2015-11-27
JP5627062B1 (ja) 2014-11-19
ES2638420T3 (es) 2017-10-20
JPWO2014163132A1 (ja) 2017-02-16
CN104334169B (zh) 2016-11-02
KR20150138800A (ko) 2015-12-10
EP2826477B1 (de) 2017-05-31
BR112014029538B1 (pt) 2022-07-05
CA2870675C (en) 2017-03-28
US20150079166A1 (en) 2015-03-19
TWI645863B (zh) 2019-01-01
TW201517932A (zh) 2015-05-16
CA2870675A1 (en) 2014-10-09
CN104334169A (zh) 2015-02-04
BR112014029538A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
IN2014MN02116A (de)
EA201690598A1 (ru) Аминогетероарил бензамиды в качестве ингибиторов киназы
NZ714283A (en) Novel histone deacetylase inhibitors
PH12018501099A1 (en) Novel biphenyl compound or salt thereof
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
DK2840080T3 (da) Nitrogenholdig heterocyklisk forbindelse eller salt deraf
EA201690247A1 (ru) Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения
NZ716840A (en) Combination formulation of two antiviral compounds
MD20140072A2 (ro) Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
GEP201706671B (en) Heterocyclyl compounds as mek inhibitors
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
PH12015501752B1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
EA201692548A1 (ru) Минеральные аминокислотные комплексы активных веществ
EA201690911A1 (ru) Соединения диметилбензойной кислоты
EA201592268A1 (ru) Дигидропиридиноновые ингибиторы mgat2
WO2016068580A3 (en) Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms)
MX390763B (es) Compuestos de tetraciclina
MX2015015841A (es) Compuestos de fenoxietil dihidro-1h-isoquinolina.
MX362919B (es) Moduladores del receptor acoplado a proteína-g 120 (gpr120) de ácido biciclo-[2.2.1].
PH12016500577A1 (en) Piperazine derivatives and the use thereof as medicament
EP4282973A3 (de) Herstellungsverfahren für pyrimidincyclopentanverbindungen
EA201790522A1 (ru) Соль производного цефалоспорина, ее кристаллическое твердое вещество и способ ее получения
EA201400473A1 (ru) Способ синтеза 3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбонитрила и применение для синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
GEP20186874B (en) Hydrochloride salts of an antibiotic compound